Hydroxychloroquine Has About 90 Percent Chance of Helping COVID-19 Patients
“In a letter to Gov. Doug Ducey of Arizona, the Association of American Physicians and Surgeons (AAPS) presents a frequently updated table of studies that report results of treating COVID-19 with the anti-malaria drugs chloroquine (CQ) and hydroxychloroquine (HCQ, Plaquenil®).
To date, the total number of reported patients treated with HCQ, with or without zinc and the widely used antibiotic azithromycin, is 2,333, writes AAPS, in observational data from China, France, South Korea, Algeria, and the U.S. Of these, 2,137 or 91.6 percent improved clinically. There were 63 deaths, all but 11 in a single retrospective report from the Veterans Administration where the patients were severely ill.”
Why is there a never ending attack on hydroxychloroquine? It is true that observational data is not the double blind, placebo controlled, gold standard that everyone is clamoring about. But this doesn’t mean observational data is not of any value. The doctors who use this medication say it works. They are on the front lines of treating COVID-19 and can see the results for themselves. I think the push-back is because President Trump recommended it. It’s the only logical conclusion. Now the Association of American Physicians and Surgeons, a national medical organization is standing up for what appears to be right. There is growing evidence that this treatment works.
For more information on lifestyle medicine, pain treatment, regenerative medicine, CBD, ozone, nutrition or any of the other wonderful integrative medicine services we provide, please contact the practice of Dr. Scott Denny with a practice location in Davie, Florida. Please visit http://www.drscottdenny.com to receive a copy of Dr. Denny’s free acupuncture eBook.